Chris Boerner

(Dr. Christopher Boerner Ph.D.)

Currently holds a position at Bristol-Myers Squibb Co

Positions

Position Company Period
Executive Vice President and Chief Commercial Officer Bristol-Myers Squibb Co Aug. 28, 2018 -
Independent Director Achaogen Inc March 27, 2015 - June 10, 2015
Executive Vice President - Commercial Seagen Inc Feb. 10, 2014 - Jan. 30, 2015
Senior Vice President - Commercial Seagen Inc March 1, 2012 - Feb. 10, 2014
Chris Boerner's trades of Bristol-Myers Squibb Co's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-02-21 2025-02-20 B Purchase
2,000 +1.9%
55.05
USD 110,096
2,000 +1.9% 55.05 USD 110,096
2023-12-07 2023-12-05 B Purchase
2,000 +2.5%
49.78
USD 99,560
2,000 +2.5% 49.78 USD 99,560
2023-11-30 2023-11-28 B Purchase
3,071 +4.0%
48.86
USD 150,049
3,071 +4.0% 48.86 USD 150,049
2022-03-16 2022-03-14 S Sale
29,532 -41.3%
69.20
USD 2,043,526
29,532 -41.3% 69.20 USD 2,043,526
// ... existing code ... // ... rest of the file ...